VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

CUSIP: 921937819

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / INTERMED TERM
Total 13F shares
66,069,381
Share change
+9,706,171
Total reported value
$5,488,700,296
Put/Call ratio
100%
Price per share
$83.06
Number of holders
263
Value change
+$805,593,335
Number of buys
134
Number of sells
83

Security key

921937819

Report period

Q4 2015

Institutions

263

Top holders

10

Ownership snapshot

Top shareholders of BIV - VANGUARD BD INDEX FDS - INTERMED TERM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2015

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
263
Shares
66,069,381
Rows loaded
263
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2015 vs Q3 2015 Across Filers

Q3 2015 holders
231
Q4 2015 holders
263
Holder diff
32
Investor Q3 2015 Shares Q4 2015 Shares Share Diff Share Chg % Q3 2015 value Q4 2015 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .